- Investing Ideas
- /
- U.K. Pharmaceuticals & Biotech Potentially Undervalued Companies
U.K. Pharmaceuticals & Biotech Potentially Undervalued Companies
Results
195
Companies with a Value score of at least 3, ordered by Value score
195 companies
Merck KGaA
Market Cap: €47.0b
Operates as a science and technology company in Germany.
0O14
€108.30
7D
0.6%
1Y
-30.4%
Emergent BioSolutions
Market Cap: US$436.4m
A life sciences company, provides preparedness and response solutions for accidental, deliberate, and naturally occurring public health threats in the United States.
0IGA
US$8.10
7D
1.8%
1Y
35.9%
H. Lundbeck
Market Cap: DKK 43.4b
Engages in the research, development, manufacturing, and commercializing pharmaceuticals for the treatment of psychiatric and neurological disorders in Europe, United States, and internationally.
0ABR
DKK 36.10
7D
2.6%
1Y
-5.5%
Novartis
Market Cap: US$189.4b
Researches, develops, manufactures, distributes, markets, and sells pharmaceutical medicines in Switzerland and internationally.
0K9E
US$123.10
7D
0.5%
1Y
5.3%
Photocure
Market Cap: NOK 1.5b
Engages in the research, development, production, distribution, marketing, and sale of pharmaceutical products.
0IMT
NOK 58.70
7D
-1.2%
1Y
11.8%
Agios Pharmaceuticals
Market Cap: US$2.2b
A biopharmaceutical company, discovers and develops medicines in the field of cellular metabolism in the United States.
0HB0
US$38.17
7D
0.5%
1Y
-19.3%
Bavarian Nordic
Market Cap: DKK 18.0b
Develops, manufactures, and supplies life-saving vaccines.
0DPB
DKK 230.50
7D
-0.6%
1Y
-4.6%
Cellectis
Market Cap: €222.0m
A clinical stage biotechnological company, develops products based on gene-editing with a portfolio of allogeneic chimeric antigen receptor T-cells product candidates in the field of immuno-oncology and gene therapy product candidates in other therapeutic indications.
0WA2
€3.09
7D
13.7%
1Y
62.4%
Novo Nordisk
Market Cap: DKK 1.7t
Engages in the research and development, manufacture, and distribution of pharmaceutical products in Europe, the Middle East, Africa, Mainland China, Hong Kong, Taiwan, North America, and internationally.
NOVOBC
DKK 374.75
7D
5.7%
1Y
-55.6%
H. Lundbeck
Market Cap: DKK 43.4b
Engages in the research, development, manufacturing, and commercializing pharmaceuticals for the treatment of psychiatric and neurological disorders in Europe, United States, and internationally.
0ND5
DKK 45.70
7D
4.6%
1Y
3.5%
Evotec
Market Cap: €1.1b
Operates as a drug discovery and development company in the United States, Germany, France, the United Kingdom, Switzerland, and internationally.
0IRF
€6.19
7D
0.06%
1Y
4.4%
Genmab
Market Cap: DKK 115.0b
A biotechnology company, develops antibody-based products and product candidates for the treatment of cancer and other diseases in Denmark.
0MGB
DKK 1,851.98
7D
5.4%
1Y
15.4%
Newron Pharmaceuticals
Market Cap: CHF 217.6m
A biopharmaceutical company, discovers and develops novel therapies for patients with diseases of the central and peripheral nervous system in Italy and the United States.
0QOI
CHF 10.54
7D
11.2%
1Y
38.5%
Pfizer
Market Cap: €137.0b
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States and internationally.
PFED
€20.74
7D
1.5%
1Y
-18.8%
Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt
Market Cap: Ft1.8t
Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt.
0QFP
Ft10,400.00
7D
0%
1Y
-3.9%
Oxford Biomedica
Market Cap: UK£699.5m
A contract development and manufacturing organization, focuses on delivering therapies to patients worldwide.
OXBL
UK£5.84
7D
-0.7%
1Y
56.8%
Abeona Therapeutics
Market Cap: US$282.5m
A clinical-stage biopharmaceutical company, develops gene and cell therapies for life-threatening diseases.
0H7R
US$5.60
7D
-0.4%
1Y
-5.3%
Sangamo Therapeutics
Market Cap: US$159.1m
A clinical-stage genomic medicine company, focuses on translating science into medicines that transform the lives of patients and families afflicted with serious diseases in the United States.
0R1D
US$0.55
7D
2.4%
1Y
-39.3%
Organon
Market Cap: US$2.7b
Develops and delivers health solutions through prescription therapies and medical devices in the United States, Europe, Canada, Japan, rest of the Asia Pacific, Latin America, the Middle East, Russia, Africa, and internationally.
0A9W
US$10.43
7D
-3.1%
1Y
-45.4%
Exelixis
Market Cap: US$10.7b
An oncology company, focuses on the discovery, development, and commercialization of new medicines for difficult-to-treat cancers in the United States.
0IJO
US$38.79
7D
-4.4%
1Y
48.5%
Bristol-Myers Squibb
Market Cap: US$91.4b
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, markets, distributes, and sells biopharmaceutical products worldwide.
0R1F
US$44.37
7D
-4.3%
1Y
-11.3%
Novo Nordisk
Market Cap: US$1.7t
Engages in the research and development, manufacture, and distribution of pharmaceutical products in Europe, the Middle East, Africa, Mainland China, Hong Kong, Taiwan, North America, and internationally.
0TDD
US$58.25
7D
-0.4%
1Y
-54.0%
UroGen Pharma
Market Cap: US$827.2m
Engages in the development and commercialization of solutions for urothelial and specialty cancers.
0XOD
US$17.89
7D
-2.1%
1Y
38.8%
Heron Therapeutics
Market Cap: US$227.3m
A commercial-stage biotechnology company, engages in developing and commercializing therapeutic that enhances medical care.
0J4V
US$1.25
7D
0.4%
1Y
-33.7%
BioMarin Pharmaceutical
Market Cap: US$10.3b
A biotechnology company, engages in the development and commercialization of therapies for life-threatening rare diseases and medical conditions in the United States, Europe, Latin America, the Middle East, the Asia Pacific, and internationally.
0HNC
US$53.39
7D
-2.9%
1Y
-22.5%
Haleon
Market Cap: UK£29.5b
Engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific.
HLN
UK£3.30
7D
-3.4%
1Y
-16.0%
Gerresheimer
Market Cap: €1.3b
Provides medicine packaging, drug delivery devices, and solutions in Germany and internationally.
0NTI
€36.20
7D
-16.2%
1Y
-63.2%
Dynavax Technologies
Market Cap: US$1.1b
A commercial stage biopharmaceutical company, focuses on developing and commercializing vaccines in the United States and internationally.
0IDA
US$9.80
7D
1.4%
1Y
-9.0%
Esperion Therapeutics
Market Cap: US$500.0m
A pharmaceutical company, develops and commercializes medicines for the treatment of patients with elevated low density lipoprotein cholesterol (LDL-C) in the United States.
0IIM
US$2.46
7D
-10.9%
1Y
53.0%
SCHOTT Pharma KGaA
Market Cap: €3.3b
Develops, manufactures, and sells drug containment solutions and delivery systems for injectable drugs for pharmaceutical, biotechnology, and life science industries worldwide.
1SXPD
€24.38
7D
0%
1Y
n/a
Kuros Biosciences
Market Cap: CHF 927.5m
Engages in the commercialization and development of biologic technologies for musculoskeletal care in the United States of America, the European Union, and internationally.
0RHR
CHF 23.70
7D
0.3%
1Y
29.2%
Revvity
Market Cap: US$9.9b
Provides health sciences solutions, technologies, and services.
0KHE
US$84.73
7D
-2.5%
1Y
-31.1%
AstraZeneca
Market Cap: UK£173.8b
A biopharmaceutical company, focuses on the discovery, development, manufacture, and commercialization of prescription medicines.
AZN
UK£112.10
7D
-1.6%
1Y
-3.1%
GSK
Market Cap: UK£59.8b
Engages in the research, development, and manufacture of vaccines, specialty medicines, and general medicines to prevent and treat disease in the United Kingdom, the United States, and internationally.
GSK
UK£14.85
7D
0.8%
1Y
-2.8%
Apontis Pharma
Market Cap: €72.1m
Engages in the marketing and sale of medical drugs for indication fields of internal medicine in Germany.
APPHD
€6.37
7D
0%
1Y
n/a
Novo Nordisk
Market Cap: €1.6t
Engages in the research and development, manufacture, and distribution of pharmaceutical products in Europe, the Middle East, Africa, Mainland China, Hong Kong, Taiwan, North America, and internationally.
NOVD
€62.00
7D
0%
1Y
n/a